STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
52 hedge funds and large institutions have $396M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.71M | |
| 2 | +$9.46M | |
| 3 | +$6.47M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.96M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$14.2M | |
| 3 | -$13.5M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.17M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$280K |